nsaids may protect against age-related brain atrophy

Clicks: 276
ID: 216916
2010
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Star

Ranked #127 of 234 articles by views in Frontiers in chemistry

Most read Least read

Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 234 in total.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
The use of non-steroidal anti-inflammatory drugs (NSAIDs) in humans is associated with brain differences including decreased number of activated microglia. In animals, NSAIDs are associated with reduced microglia, decreased amyloid burden, and neuronal preservation. Several studies suggest NSAIDs protect brain regions affected in the earliest stages of AD, including hippocampal and parahippocampal regions. In this cross-sectional study, we examined the protective effect of NSAID use on gray matter volume in a group of middle-aged and older NSAID users (n = 25) compared to non-user controls (n = 50). All participants underwent neuropsychological testing and T1-weighted magnetic resonance imaging. Non-user controls showed smaller volume in portions of the left hippocampus compared to NSAID users. Age-related loss of volume differed between groups, with controls showing greater medial temporal lobe volume loss with age compared to NSAID users. These results should be considered preliminary, but support previous reports that NSAIDs may modulate age-related loss of brain volume.
Reference Key
bendlin2010frontiersnsaids Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors ;Barbara B Bendlin;Barbara B Bendlin;Lisa M Newman;Lisa M Newman;Michele L Ries;Michele L Ries;Luigi Puglielli;Luigi Puglielli;Cynthia M Carlsson;Cynthia M Carlsson;Mark A Sager;Mark A Sager;Howard A Rowley;Catherine L Gallagher;Catherine L Gallagher;Auriel A Willette;Auriel A Willette;Andrew L Alexander;Andrew L Alexander;Andrew L Alexander;Sanjay Asthana;Sanjay Asthana;Sterling C Johnson;Sterling C Johnson
Journal Frontiers in chemistry
Year 2010
DOI
10.3389/fnagi.2010.00035
URL
http://journal.frontiersin.org/Journal/10.3389/fnagi.2010.00035/full
Keywords
Risk factors aging alzheimer's disease nsaids neuropsychiatry biological psychiatry volumetric mrineurosciences

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.